Aquigen Bio Sciences

  In the field of pharmaceutical development and quality control, the identification and characterization of drug impurities are crucial. One such active pharmaceutical ingredient (API) that requires rigorous impurity profiling is   Atovaquone , commonly used for treating pneumocystis pneumonia and malaria. Among its impurities,   Atovaquone Impurity 1   holds particular importance due to its relevance in drug stability and safety assessments. In this blog, we delve into  Atovaquone Impurity 1 , its significance, and how it relates to other impurities such as  Atovaquone Impurity 2 ,  3 ,  4 , and  5 . What is Atovaquone Impurity 1? Atovaquone Impurity 1  is a known degradation product or synthetic by-product that can form during the manufacturing or shelf life of Atovaquone. Its presence is typically monitored as part of the ICH guidelines for impurities in pharmaceuticals (ICH Q3A and Q3B). Chemical Nature : Typically, this impurity ma...

Drospirenone  is a synthetic progestin commonly used in combination with estrogen in various hormonal contraceptives and hormone replacement therapies. Known for its effectiveness, drospirenone mimics the natural hormone progesterone in the body. Its unique properties make it stand out among other synthetic progestins, offering distinct advantages and a slightly different side effect profile. While drospirenone has garnered significant attention for its medical applications, the pharmaceutical industry also places a strong emphasis on quality standards when producing and developing this compound. At Aquigen Bio Sciences, we pride ourselves on being a trusted partner for drospirenone impurity standards in India. By delivering high-quality impurity reference standards, we support pharmaceutical companies in creating precise formulations that meet global safety and efficacy requirements. This blog by our experts delves into the uses, benefits, potential side effects of drospirenone, a...

  Introduction In the intricate realm of pharmaceutical synthesis and quality control, impurities are crucial for assessing the safety, effectiveness, and reliability of active pharmaceutical ingredients (APIs). One impurity that’s been making waves is Gefitinib EP Impurity A, a vital reference standard for evaluating  Gefitinib , a tyrosine kinase inhibitor primarily used in the treatment of non-small-cell lung cancer (NSCLC). What is Gefitinib EP Impurity A? Gefitinib EP Impurity A  is a compound that can form during the synthesis, storage, or breakdown of Gefitinib. It’s recognized in pharmacopoeial monographs, such as the European Pharmacopoeia (EP), and is carefully monitored to meet regulatory standards and maintain the therapeutic quality of the final product. At Aquigen BioSciences, we provide high-purity Gefitinib EP Impurity A as a certified reference material. This is essential for: - Developing analytical methods - Profiling impurities - Conducting stability s...